Table 1.
Laboratory biomarkers of coronavirus disease 2019 (COVID-19) patients according to the presence or absence of neuropathic post-COVID pain symptoms at 6 months after hospital discharge
| S-LANSS ≥ 12 points | S-LANSS < 12 points | P value | |
|---|---|---|---|
| (n = 18) | (n = 49) | ||
| Glucose (mg/mL) | 118.7 (59.0) | 110.0 (28.0) | .453 |
| Creatinine (mg/dL) | 0.9 (0.2) | 0.9 (0.4) | .844 |
| Alanine transaminase (ALT, U/L) | 24.8 (10.1) | 25.4 (11.7) | .864 |
| Aspartate transaminase (AST, U/L) | 22.5 (7.1) | 22.7 (6.4) | .938 |
| Lactate dehydrogenase (LDH, U/L) | 213.5 (32.7) | 207.1 (45.1) | .583 |
| Creatine kinase (CK, mg/dL) | 1.5 (2.5) | 1.0 (0.4) | .224 |
| Albumin (g/dL) | 4.5 (0.2) | 4.55 (0.3) | .424 |
| Ferritin (ng/mL) | 147.2 (187.1) | 125.9 (119.8) | .584 |
| Leucocytes (×109/L) | 6.9 (1.7) | 7.25 (1.5) | .419 |
| Lymphocytes (×109/L) | 3.4 (0.8) | 3.1 (0.75) | .202 |
| Eosinophils (×109/L) | 2.5 (1.9) | 2.7 (2.7) | .786 |
| Hemoglobin (g/dL) | 13.9 (1.1) | 14.2 (1.5) | .453 |
| Platelets (×109/L) | 238.1 (69.5) | 251.0 (54.25) | .427 |
| Erythrocyte sedimentation rate (ESR, mm/h) | 16.1 (17.65) | 10.2 (9.3) | .117 |
| Fibrinogen (mg/dL) | 432.3 (102.1) | 403.85 (80.9) | .242 |
| D-dimer (ng/mL) | 665.5 (879.7) | 513.5 (404.5) | .339 |
n = number; SD = Standard Deviation.